Introduction
============

Enterohemorrhagic *Escherichia coli* (EHEC) cause human disease ranging from self-limited watery diarrhea to the life-threatening condition of hemorrhagic colitis and its sequelae -- the hemolytic uremic syndrome (HUS; Karmali et al., [@B34]; Paton and Paton, [@B55]). *E. coli* O157:H7 is the predominate EHEC serotype isolated from disease outbreaks in North America, the United Kingdom, and Japan (Griffin and Tauxe, [@B28]; Smith, [@B67]; Mead et al., [@B46]; Michino et al., [@B48]). Healthy cattle are the major reservoir for *E. coli* O157:H7, the most common source for human infections (Hancock et al., [@B29]; Zhao et al., [@B74]; Chapman et al., [@B6]), and carry the bacteria with no apparent disease symptoms (Blanco et al., [@B4]; Besser et al., [@B3]; Hancock et al., [@B30]). Previous studies demonstrate that the recto-anal junction (RAJ) mucosa is the primary site of *E. coli* O157:H7 colonization in cattle (Grauke et al., [@B27]; Naylor et al., [@B51]; Cobbold et al., [@B7]; Dean-Nystrom et al., [@B11]), and the carriage of *E. coli* O157:H7 at this site is correlated to high level fecal shedding (Low et al., [@B41]). Rectal administration of *E. coli* O157:H7 results in efficient bacterial colonization at the RAJ mucosa that is maintained for \>1 month (Sheng et al., [@B62], [@B64]). Because the terminal rectal mucosa may be the ideal target for controlling *E. coli* O157:H7 in cattle, we and others have applied O157-specific lytic bacteriophages (Sheng et al., [@B63]; Rivas et al., [@B58]) or chemical chlorhexidine (Naylor et al., [@B52]) directly to this location. However, when these treatments are effective they reduce the level of the *E. coli* O157:H7 carriage, but never completely eliminate *E. coli* O157:H7 from the rectal mucosa.

Enterohemorrhagic *E. coli* and enteropathogenic *E. coli* (EPEC) belong to the "attaching and effacing (A/E) pathogen" category because of their ability to induce A/E lesions on intestinal epithelial cells. The characteristics of the A/E lesions include the localized effacement of the brush border microvilli, intimate bacterial attachment to the host epithelium, and the formation of cytoskeleton-rich pedestal-like structures beneath the adherent bacteria (Moon et al., [@B49]). The A/E pathogens share a highly homologous mobile genetic element called the locus of enterocyte effacement (LEE) pathogenicity island that is responsible for A/E lesion formation (McDaniel and Kaper, [@B45]; Hueck, [@B32]; Elliott et al., [@B19], [@B18]). The LEE encodes a type III secretion system (T3SS), secreted proteins, chaperone, and regulatory molecules, and an outer membrane adhesion protein called intimin (Perna et al., [@B56]; Elliott et al., [@B19]). The T3SS is responsible for translocating into infected cells both LEE- and non-LEE-encoded (Nle)-effectors, including translocated intimin receptor (Tir), EspA, EspB, and EspD (Kenny et al., [@B36]; Knutton et al., [@B37]; Kenny, [@B35]). Tir is inserted into the host cell plasma membrane with Tir--intimin interaction triggering signaling events leading to pedestal formation (Rosenshine et al., [@B59]; Kenny et al., [@B36]). There are a number of studies that show the LEE encoding effector proteins play a role in ruminant intestinal colonization *in vivo* (Dean-Nystrom et al., [@B10]; Cornick et al., [@B8]; Dziva et al., [@B17]; Naylor et al., [@B53]; Sheng et al., [@B64]; Vlisidou et al., [@B72]).

Enteropathogenic *E. coli* is usually considered an extracellular organism but under *in vitro* conditions bacteria can be seen intracellularly and this phenotype is dependent on a functional T3SS (Francis et al., [@B25]; Rosenshine et al., [@B59]; Jepson et al., [@B33]). The effecter EspT facilitates EPEC internalization into non-phagocytic cells in a process involving Rac1 and Wave2 (Bulgin et al., [@B5]). In fact, in addition to the generation of intimate adherence and the A/E lesions, EHEC strains, like EPEC, are capable of efficient entry into a variety of epithelial cell types (Dibb-Fuller et al., [@B12]; Martinez and Hultgren, [@B43]; Uhlich et al., [@B71], [@B70]; Abu-Ali et al., [@B1]), though they are also regarded as extracellular pathogens. Internalization of EHEC O157:H7 by human epithelial cells is also known (Oelschlaeger et al., [@B54]) and Dibb-Fuller et al. ([@B12]) demonstrate *E. coli* O157:H7 is internalized in several distinct bovine cell lines. The interaction of *E. coli* O157:H7 with bovine host cells and the mechanism(s) that lead to the specific tropism and persistence at the rectal mucosa are not fully understood. We speculated that the bovine epithelial cells at the terminal rectal mucosa may internalize a subpopulation of *E. coli* O157:H7 and these intracellular bacteria may contribute to the persistence of *E. coli* O157:H7 at this colonization site. The aims of this study were to (1) describe *E. coli* O157:H7 in biopsy tissue taken from *E. coli* O157:H7 culture positive cattle; and (2) investigate the internalization of *E. coli* O157:H7 using primary bovine rectal epithelial (PBRE) cells.

Materials and Methods
=====================

Bacteria and culture
--------------------

All strains used in this study are listed in Table [1](#T1){ref-type="table"}. The clinical isolates were chosen because they are well characterized human pathogens and two have full DNA sequence known (ATCC 43895, also referred to as EDL933, and Sakai). All have been used previously by our laboratory and others in cattle trails of *E. coli* O157:H7 carriage. *E. coli* O157:H7 and other *E. coli* strains were grown in Luria--Bertani (LB) broth or agar. Recombinant *E. coli* O157:H7 43894 GFPuv was grown in LB with 100 μg/ml ampicillin.

###### 

**Bacterial strains used in this study**.

  Strains          Description                                                                                 Source or reference                              
  ---------------- ------------------------------------------------------------------------------------------- --------------------------------------------- -- --
  43895 (EDL933)   *E. coli* O157:H7 ATCC 43895, a clinical isolate from ground beef, *stx1*^+^/*stx2*^+^      ATCC                                             
  43894            *E. coli* O157:H7 ATCC 43894, a clinical isolate from human stool, *stx1*^+^/*stx2*^+^      ATCC                                             
  Sakai            *E. coli* O157:H7, a clinical isolate, *stx1*^+^/*stx2*^+^                                  Lim et al. ([@B40]), Tatsuno et al. ([@B69]      
  43894 GFPuv      43894 carry pCRII-GFPuv and produces strong fluorescence when excited by UV light. Amp^R^   Laboratory stock                                 
  43895Δ*eae*      43895 with intimin gene deletion                                                            Sheng et al. ([@B64])                            
  43895Δ*tir*      43895 with Tir gene deletion                                                                Sheng et al. ([@B64])                            
  43894Δ*eae*      43894 with intimin gene deletion                                                            This work                                        
  43894Δ*tir*      43894 with Tir gene deletion                                                                This work                                        
  WSU180           *E. coli* O157:H7, a bovine isolate, *stx1*^+^/*stx2*^+^                                    Rice et al. ([@B57])                             
  K-12             *E. coli* MG1655 strain                                                                     Laboratory stock                                 

*ATCC, American type culture collection, Manassas, VA, USA*.

Gene manipulation
-----------------

To make a mutant deficient in expression of intimin or Tir in *E. coli* O157:H7 43894, the λ-Red recombinase system (Datsenko and Wanner, [@B9]) was used for *eae* or *tir* gene deletion, respectively. The plasmid pKD4 was used as a template to amplify a kanamycin resistance gene, and the same primers were used as described, previously (Sheng et al., [@B64]).

Cattle challenge
----------------

All animal procedures were approved by the Institutional Animal Care and Use and Biosafety Committees and were strictly followed in this study. Seven to 10-month-old Holstein steers were housed in a quarantined facility at the University of Idaho Agriculture Experiment Station as previous described (Sheng et al., [@B64]). Steers were given a single rectal application of 10^7^ CFU of *E. coli* O157:H7 strains 43895, 43894, or 43894 GFPuv as previously described (Sheng et al., [@B62]). Retrospective analysis of strain persistence used previously published and unpublished cattle rectal application challenge culture data collected by our laboratory since 2004 (Kudva et al., [@B38]; Sheng et al., [@B64]; and unpublished data).

Preparation of rectal biopsy tissue
-----------------------------------

Feces were manually removed from the cattle rectum and mucosal biopsies were taken from the rectal mucosa 10--15 cm proximal to the anus using a standard bone curette. The wet weights of biopsy tissues ranged from 30 to 60 mg. The biopsy tissues were rinsed with cold phosphate buffered saline (PBS) and held in cold Hanks' balanced salt solution (HBSS) on ice for transport to the laboratory.

Tissue-embedded *E. coli* O157:H7 recovery assay
------------------------------------------------

The terminal rectal tissue biopsies from *E. coli* O157:H7 culture positive cattle were transferred into sterile 10-cm Petri dishes with 15 ml PBS, fecal debris, and clotted blood was trimmed away and the remaining tissue was cut into fine pieces with sterile scissors. The minced tissue was recovered by centrifugation at 500×*g* for 5 min, the supernatant was removed, 100 μg/ml gentamicin in HBSS was added, and the tissue was incubated with shaking (150 rpm) at 37°C for 2 h to kill extracellular bacteria. The biopsy tissues were then washed three times with PBS, lysed with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) in PBS by vigorous vortexing. Serial dilutions of the mixture were plated on sorbitol MacConkey agar (SMAC) supplemented with cefixime (50 μg/l; Lederle Laboratories), potassium tellurite (2.5 mg/l; Sigma), vancomycin (40 mg/l; Sigma), and 4-methylumbelliferyl-β-[d]{.smallcaps}-glucuronide (0.1 μg/ml, Biosynth AG, Staad, Switzerland). The plates were incubated at 37°C overnight. *E. coli* O157:H7 colonies were identified and confirmed as O157 by latex agglutination as previous described (Sheng et al., [@B65]).

Preparation of tissue biopsies for microscopy
---------------------------------------------

To prepare cryostat sections, biopsy tissues from the terminal rectum of 43894 GFPuv culture positive and negative control cattle were fixed with 4% (w/v) paraformaldehyde for 30 min, and infiltrated with up to 25% (w/v) sucrose in PBS (7.5, 15, 25% step gradient). Tissue was oriented to obtain optimal apical to basolateral cryostat cross sections (5--10 μm) that were placed on polylysine-coated slides, air dried, and observed using fluorescence microscopy.

Primary bovine epithelial cell isolation and cell culture
---------------------------------------------------------

Primary bovine rectal epithelial cells were isolated from rectal biopsies as described by others with some modifications (Follmann et al., [@B24]; Dziva et al., [@B16]; Stamm et al., [@B68]). Briefly, rectal biopsies were taken from *E. coli* O157:H7 negative steers, cleaned, and cut as described above. The treated tissues were digested in Dulbecco\'s modified Eagle medium (DMEM) containing 1% (v/v) heat-inactivated fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin (Invitrogen), 30 mg/ml streptomycin (Invitrogen), 25 mg/ml gentamicin (Invitrogen), 75 U/ml collagenase (Sigma), and 20 mg/ml accutase (Millipore, Billerica, MA, USA) with gentle shaking at 37°C until isolated crypts were observed under microscopy. A series of differential centrifugation steps with DMEM containing 2% (w/v) sorbitol was used to enrich the disassociated crypts. The crypt cell pellet was resuspended in cell culture medium \[DMEM, 2.5% (v/v) FBS, 0.25 U/ml insulin (Sigma), 10 ng/ml epidermal growth factor (EGF; Sigma), 100 U/ml penicillin, 30 mg/ml streptomycin, and 30 mg/ml gentamicin\]. Approximately 400 crypts are seeded per well into 24-well culture plates precoated with collagen (Becton Dickinson Labware, Bedford, MA, USA). Media was supplemented with 100 μg/ml *cis-*OH-proline (Sigma) to selectively eliminate fibroblasts from the cultures (Willis et al., [@B73]). Confluence of the cultured cells was reached within 6--7 days and contained approximately 1.8 × 10^5^ cells/well. The characteristics of the epithelial cells were confirmed by immunocytochemistry as described previously (Hoey et al., [@B31]).

Adherence and internalization assays
------------------------------------

The bacterial internalization by the PBRE cells was measured using a standard gentamicin protection assay (Small et al., [@B66]; Matthews et al., [@B44]). Monolayers of the PBRE cells were washed twice with HBSS and infected with 1 ml of the cell culture medium without antibiotics and FBS (internalization medium) at a MOI of 100 bacteria/epithelial cell. After 4 h incubation at 37°C with 5% CO~2~, unattached extracellular bacteria were removed using a serological pipette and the infected monolayers were washed three times with HBSS. The total number of cell-associated bacteria (adhered and internalized) were measured by disrupting the monolayers for 10 min with 0.1% Triton X-100 in 0.1 M PBS (pH 7.2) and gentle vortexing. Serial dilutions were plated on LB agar to determine bacterial numbers. A standard Giemsa stain procedure was used in replicate sample wells to view the interaction of the bacteria with PBEC cells, microscopically. For measurement of internalization, fresh internalization medium containing 100 μg/ml of gentamicin was added to kill adhered extracellular bacteria. After incubation for an additional 2 h, the monolayers were washed three times with HBSS without Ca^2+^ or Mg^2+^ and epithelial cells were lysed by addition of 100 μl of 0.5% trypsin--EDTA (Sigma) and 900 μl of 0.05% Triton X-100 for 5 min. Samples were removed, serially diluted, and plated on LB agar to determine the number of CFU. Internalization levels were expressed as the number of CFU recovered/well or as a percentage of the original inoculum resisting gentamicin treatment.

Internalization inhibition assay
--------------------------------

To assess the effect of eukaryotic cell inhibitors on bacterial internalization, the PBRE cell monolayers were incubated with cytochalasin D (1 μg/ml, Sigma), colchicine (1.25 μM, Sigma), compactin (25 μM, Sigma), or genistein (50 μM, Sigma) prior to addition of bacteria as described previously (Matthews et al., [@B44]). Cytochalasin D and colchicine were added to the monolayers 30 min prior to inoculation, genistein 15 min prior to inoculation, and compactin 18 h prior to inoculation. All of the inhibitors were present throughout the 4-h bacterial incubation period. Controls verified that inhibitors did not affect eukaryotic cell viability by trypan blue exclusion and bacterial viability by plate count. Data are expressed as means of the averages obtained from three experiments.

Immunofluorescence microscopy
-----------------------------

To visualize the location of *E. coli* O157:H7 in the biopsy tissue sections, 43894 GFPuv which expresses green fluorescent protein was applied at the rectal mucosa of two steers. The GFP carry-plasmid was stable in 43894 without antibiotic supplement. The cryostat sections were examined by epifluorescence microscopy using an Olympus BX51 microscope with a 100× oil immersion objective (Olympus, Tokyo, Japan). Digital images were acquired using an Olympus DP-70 digital camera and merged using DP manager software version 1.1.1.71.

Electron microscopy
-------------------

The PBRE cells were infected with 43894 or 43895 for 4 h and fixed in 2.5% glutaraldehyde 2% paraformaldehyde in 0.1 M cacodylate buffer, followed by post-fixation in 2% osmium tetroxide in 0.1 M in 0.1 M cacodylate buffer for 1 h. The cells were dehydrated in an ethanol series, followed twice by 100% acetone, infiltrated with Spurr\'s resin and polymerized overnight at 70°C. Thin (90 nm) sections were stained with 4% uranyl acetate and Reynolds lead before viewing with a JEOL 1200 EX JEM transmission electron microscope located at the Franceschi Microscopy and Imaging Center (FMIC), Washington State University; Pullman, WA, USA.

Biofilm formation assay
-----------------------

The biofilm formation assay was performed using a microtiter plate method as described previously (Djordjevic et al., [@B13]) with some modifications. Briefly, a single colony of each *E. coli* O157:H7 strain was inoculated into 4 ml LB broth and incubated at 37°C overnight with aeration. Then, 5 μl overnight culture was inoculated into 96 well microtiter plates (Corning, Inc., New York, NY, USA) containing 160 μl minimal salt medium (MSM) supplemented with 1 mg/l of yeast extract and 0.04% glucose and incubated at 37°C for 24 h under stationary conditions. Each strain was inoculated in triplicate. Following incubation the plates were washed vigorously with DI water and stained for 15 min with crystal violet (1%) and rinsed vigorously with DI water again to remove unattached cells and residual dye. Biofilm formation was evaluated by measuring the absorbance of solubilized dye in 95% ethanol at 595 nm using a PowerWave XS plate reader (Bio-Tek, Winooski, VT, USA). The biofilm formation experiments were performed in triplicate.

Statistical analysis
--------------------

Graphs were drawn using Microsoft Excel and GraphPad Prism software 4.0 (San Diego, CA, USA). The numbers of *E. coli* O157:H7 recovered from gentamicin protection assay were transformed to log~10~ values. The data were analyzed by GraphPad Prism software 4.0. The data were analyzed by the chi-square test unless the variables needed the Statistical Analysis\'s *t* test procedure. For retrospective analysis of strain persistence, survival analysis was used to compare the duration of *E. coli* O157:H7 infections of two groups of cattle rectally inoculated with 43895 or 43894. Survival time was defined as the number of days a rectal swab sample was continuously cultured positive for *E. coli* O157:H7. The Log-rank (Mantel--Cox) test was conducted to evaluate the statistical significance of the difference between durations of carriage caused by 43895 and 43994.

Results
=======

*E. coli* O157:H7 in biopsy tissue survived gentamicin treatment and was deep in the mucosal crypts
---------------------------------------------------------------------------------------------------

To determine if *E. coli* O157:H7 were internalized by bovine epithelial cells at the terminal rectum, rectal tissue biopsies from culture positive cattle were analyzed using a gentamicin protection assay. Two groups of cattle received rectal application of *E. coli* O157:H7 strain 43895 or 43894 at day 0, and rectal tissue was biopsied on days 1, 4, and 7 post-challenge. The average tissue sample was 47 mg and contained 12 crypts (data not shown). Table [2](#T2){ref-type="table"} shows that the number of *E. coli* O157 recovered from rectal biopsy tissues after 2 h gentamicin treatment. On each sampling time (day 1, 4, and 7), higher numbers of the bacteria were recovered after gentamicin treatment from the rectal biopsies of the 43895-infected cattle compared to the 43894-infected cattle (*P* \< 0.05). The data indicated that more 43895 were protected from gentamicin killing than 43894, and suggest the two strains were different in their interaction with bovine host cells.

###### 

***Escherichia coli* O157:H7 from bovine rectal tissue biopsy**.

  Strain   ATCC 43894[^a^](#tfn1){ref-type="table-fn"}   ATCC 43895[^a^](#tfn1){ref-type="table-fn"}      
  -------- --------------------------------------------- --------------------------------------------- -- --
  1        34 ± 15                                       278 ± 114[\*](#tfn4){ref-type="table-fn"}        
  4        241 ± 99                                      1788 ± 865[\*](#tfn4){ref-type="table-fn"}       
  7        30 ± 21                                       523 ± 102[\*](#tfn4){ref-type="table-fn"}        

*^a^Approximately 10^7^ CFU E. coli O157:H7 ATCC 43894 or 43895 were inoculated at the terminal rectal mucosa in two separate groups of four steers on day 0*.

*^b^CFU recovered after gentamicin treatment*.

*^c^A minimum of three biopsies were taken from each animal on each sampling day and each biopsy contained an average of 12 crypts*.

\**Indicates a higher number of 43895 recovered compared to 43894 on the respective sampling days (P \< 0.05)*.

To localize *E. coli* O157:H7 in biopsy tissue, 43894 GFPuv was applied to the terminal rectal mucosa of steers and 4 days after challenge, biopsies of rectal tissue were taken and frozen sections prepared for fluorescence microscopy. Tissue sections of the first 10 μm from the lumen side showed green fluorescent bacteria adhered to the surface of the rectal mucosa (Figure [1](#F1){ref-type="fig"}A). Interestingly, 43894 GFPuv were visible in sections 30--40 μm proximal to the lumen surface, deep within the crypt (Figure [1](#F1){ref-type="fig"}B). No fluorescent bacteria were seen in samples from culture-negative cattle (Figure [1](#F1){ref-type="fig"}C). The cellular architecture and crypt bodies were visible in tissue sections from culture-negative steers due to weak tissue autofluorescence (Figure [1](#F1){ref-type="fig"}C) and in rectal tissue biopsies stained with H and E (Figure [1](#F1){ref-type="fig"}D).

![***Escherichia coli* O157:H7 penetrated into the crypts of the bovine terminal rectal mucosa**. Cattle were challenged with *E. coli* O157:H7 43894 GFPuv by standard rectal application of bacteria and negative control animals received no bacteria. Rectal mucosal biopsies were taken using a curette 4 days post-challenge. Tissue was processed, cryosectioned, and observed by light or fluorescent microscopy. Representative biopsy sections from O157 culture-negative and -positive cattle are shown. The sections were cut sequentially from the lumen side. **(A)** *E. coli* O157:H7 43894 GFPuv (arrow) visible 10 μm from the lumen surface and **(B)** around crypts at 30--40 μm from the lumen surface. **(C)** Biopsy tissue section from an O157 culture-negative animal. **(D)** Hematoxylin and eosin-stained section showing crypts of the terminal rectal mucosa. Crypts show autofluorescence with the fluorescence microscopy (original magnification ×200).](fmicb-02-00032-g001){#F1}

PBRE cell culture was established and characterized
---------------------------------------------------

To test the internalization of *E. coli* O157:H7 by bovine rectal epithelial cells, PBRE cells were obtained from rectal tissue biopsies. After mechanical disruption and enzymatic digestion of the tissue, crypt bodies were obtained (Figure [2](#F2){ref-type="fig"}A). With appropriate culture conditions and cell densities, a confluent epithelial cell layer derived from the crypts was obtained after ∼6 days (Figure [2](#F2){ref-type="fig"}B). The epithelial characteristics of the cultured cells were confirmed using pan-cytokeratin antibody specific for the intermediate filaments present in epithelial cells and anti-vimentin labeled V79 fibroblasts served as a negative control (data not shown).

![**Establishment of primary bovine rectal epithelial (PBRE) cells**. **(A)** Crypt bodies released from biopsies of the terminal rectal mucosa after 2 h enzymatic digestion at 37°C. Incubation at 37°C in supplemented DMEM medium for 6 days gave rise to **(B)** a confluence monolayer of epithelial cells. Both representative images taken by inverted microscopy (original magnification, ×100).](fmicb-02-00032-g002){#F2}

*E. coli* O157:H7 adhered to and were internalized by the PBRE cells
--------------------------------------------------------------------

Cell association and the gentamicin protection assays were employed to quantitatively assess adherence and internalization of four different *E. coli* O157:H7 strains by PBRE cells. The bacterial strains included three *E. coli* O157:H7 isolates from outbreaks of human disease: 43895, 43894, Sakai, a bovine isolate:WSU180, and a non-pathogenic laboratory strain of *E. coli*: K-12 MG1655. All strains grew at indistinguishable rates both in LB and minimal medium. Table [3](#T3){ref-type="table"} shows the numbers of cell-associated and internalized bacteria. The numbers of cell-associated and internalized bacteria varied significantly among the *E. coli* O157:H7 strains with 43895 values significantly higher compared with to 43894, Sakai, and WSU 180 (*P* \< 0.001). Not only were high numbers of 43895 internalized by the PBRE cells, but a mean of 19.38% of the original number of 43895 survived after 2 h gentamicin treatment. This higher internalization level of 43895 in the PBEC cells compared to 43894 is in agreement with the biopsy data that showed higher numbers of 43895 than 43894 were recovered from the biopsy tissues after gentamicin treatment. Cell association and internalization of *E. coli* K-12 MG1655, used as a non-pathogenic *E. coli* control, was significantly lower than all tested *E. coli* O157:H7 strains (*P* \< 0.05).

###### 

**Internalization of *E. coli* O157:H7 and K-12 by primary bovine rectal epithelial cells (*n* = 3)**.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strains          Cell-associated[^a^](#tfn5){ref-type="table-fn"}\   Internalized[^b^](#tfn6){ref-type="table-fn"}(CFU × 104/well)   \% Internalization[^c^](#tfn7){ref-type="table-fn"}      
                   (CFU × 107/well)                                                                                                                                                             
  ---------------- --------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------- -- --
  ATCC 43895       11.88 ± 3.75[\*](#tfn8){ref-type="table-fn"}        547.12 ± 110.13[\*](#tfn8){ref-type="table-fn"}                 19.38 ± 3.91[\*](#tfn8){ref-type="table-fn"}             

  ATCC 43894       2.09 ± 0.82                                         5.32 ± 2.29                                                     0.20 ± 0.09                                              

  Sakai            2.45 ± 0.73                                         5.41 ± 2.21                                                     0.19 ± 0.08                                              

  WSU180           2.23 ± 0.77                                         4.89 ± 3.05                                                     0.18 ± 0.12                                              

  *E. coli* K-12   1.02 ± 0.39                                         1.40 ± 0.49\*                                                   0.07 ± 0.02\*                                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^CFU recovered from washed, lysed monolayers after 4 h incubation with bacteria*.

*^b^CFU recovered from lysed monolayers after 4 h incubation with bacteria and 2 h gentamicin treatment*.

*^c^Percentage of inoculae surviving gentamicin treatment*.

*\*Indicates a difference (P \> 0.05) compared with the other E. coli O157:H7 strains*.

*E. coli* O157:H7 43895 were associated with PBRE cells in an aggregative pattern and internalized bacteria were in vacuoles
----------------------------------------------------------------------------------------------------------------------------

Giemsa staining showed 43895 were associated with PBRE cells with numerous bacteria aggregated together. Other tested *E. coli* O157:H7 strains, 43894 (Figure [3](#F3){ref-type="fig"}), Sakai (data not shown), and WSU180 (data not shown) had fewer PBRE cell-associated bacteria and were mostly as single bacterial cells. PBRE cells were examined by TEM 4 h post-incubation with bacteria and intracellular *E. coli* O157:H7 were observed in membrane-bound vacuoles (Figures [3](#F3){ref-type="fig"}B,C). The PBRE cells frequently internalized ten to twenty 43895 (Figure [3](#F3){ref-type="fig"}) with \>80% of PBEC cell monolayer having engulfed bacteria (data not shown), while only one to three 43894 cells were internalized (Figure [3](#F3){ref-type="fig"}) by approximately 15% of the PBEC cell monolayer (data not shown). These TEM results were consistence with the internalization assay results (Table [3](#T3){ref-type="table"}) in which a 100-fold higher recovery of 43895, compared to 43894, occurred. It also appeared that 43895 may be dividing in the PBRE vacuoles (Figure [3](#F3){ref-type="fig"}D), although this was not tested further. These data confirmed that 43895 had an exceptional ability to be internalized by bovine host cells compared to other three tested *E. coli* O157:H7 strains.

![***Escherichia coli* O15:H7 adheres to and enters the PBRE cells**. *E. coli* O15:H7 43894 or 43895 were incubated with the monolayer of PBRE cells at 100 MOI for 4 h. More 43895 bacteria adhered to and were internalized by the PBRE cells compared to 43894. **(A)** Giemsa staining showing 43895 aggregative adherence pattern (inverted microscope, original magnification, ×1000). **(B,C)** Transmission electronic microscope showing extracellular and intracellular bacteria. **(D)** 43895 appeared to divide within the vacuoles of the PBRE cells (Original magnification, ×10000).](fmicb-02-00032-g003){#F3}

*E. coli* O157:H7 43895 survived within the PBRE cells
------------------------------------------------------

To investigate the survival of *E. coli* O157:H7 in the PBRE cells, the number of intracellular bacteria was determined at various times after gentamicin exposure and expressed as percentages of the total bacteria recovered. The number of 43895 or 43894 recovered after 6 h exposure to gentamicin decreased to 42.1 and 23.2% of the total bacteria recovered at 2 h, respectively (Figure [4](#F4){ref-type="fig"}). After 24 h exposure to gentamicin, the number of intracellular bacteria was dramatically decreased. The survival rate of 43895 was decreased to 25.9% while \<1% of 43894 survived at 24 h (Figure [4](#F4){ref-type="fig"}). The number of PBRE cells attached to the wells and infected by 43895 decreased to 94% at 6 h and to 85% at 24 h of gentamicin treatment compared to the number at 2 h (data not shown). This decrease in 43895-infected cells suggested that some (6--15%) 43895-infected PBRE cells were destroyed over the course of the experiment and released bacteria that would be killed by gentamicin. Thus, the decreased number of 43895 recovered after 6 and 24 h exposure to gentamicin, may include these released cells. Almost all (\>99%) attached PBRE cells incubated with 43895 or 43894 excluded the trypan blue dye. Similar and minimal tissue culture cellular debris/destruction was noted with 43894 or 43895 during the 4-h incubation period (data not shown). In addition, the culture media containing gentamicin was tested and remained sterile indicating that the bacteria recovered were intracellular.

![**Survival of *E. coli* O157:H7 in PBRE cells**. Bacteria were incubated with monolayers of the PBRE cells at 100 MOI for 4 h. Gentamicin (100 μg/ml) was added for 2, 6, or 24 h incubation. Cells were lysed and plated to LB agar to enumerate surviving bacteria. The bacterial CFU recovered after 2 h Gentamicin treatment was set at 100%. The percentage of intracellular bacteria surviving after 6 and 24 h are shown and each value is the mean of three separate experiments.](fmicb-02-00032-g004){#F4}

Cytochalasin D inhibited internalization of *E. coli* O157:H7 by the PBRE cells
-------------------------------------------------------------------------------

To identify host cell factors involved in internalization of 43895 and 43894, PBRE cells were treated with eukaryotic cell inhibitors known to block bacterial invasion (Rosenshine et al., [@B60]; Matthews et al., [@B44]; Martinez and Hultgren, [@B43]). Treatment with cytochalasin D, an inhibitor of actin microfilaments, did not modify the number of cell-associated bacteria (*P* \> 0.05; Figure [5](#F5){ref-type="fig"}A). In contrast, its addition significantly inhibited the entry of both 43895 and 43894. The numbers of intracellular bacteria decreased by 97.4 and 99.2% at 0.5 μg/ml (*P* \< 0.001) and by 98.7 and 99.6% at 1 μg/ml concentration (*P* \< 0.001), for 43895 and 43894, respectively (Figure [5](#F5){ref-type="fig"}B). Inhibitory assays showed that colchicines, a eukaryotic microtubule formation inhibitor, compactin, a pan-Rho GTPase inhibitor, and Genistein, a tyrosine kinase inhibitor did not influence PBRE cell internalization of 43895 or 43894 (data now shown). The data indicated that the internalization process of *E. coli* O157:H7 was dependent on actin microfilament assembly.

![**Effect of cytochalasin D on *E. coli* O157:H7 association with and internalization by the PBRE cells**. The PBRE cell monolayers were pretreated with cytochalasin D for 30 min before the addition of *E. coli* O157:H7 at 100 MOI and incubated for 4 h in the presence of the inhibitor. **(A)** Total cell-associated bacteria were quantified after PBRE cell-lysis with 0.1% (v/v) Triton X-100. **(B)** Intracellular bacteria were quantified after gentamicin treatment for 2 h. Results are expressed as cell-associated or intracellular bacteria relative to those obtained without inhibitor, taken as 100%. Each value is the mean of three separate experiments.](fmicb-02-00032-g005){#F5}

Intimin and Tir are not required for *E. coli* O157:H7 internalization
----------------------------------------------------------------------

Our previous study shows that intimin and its receptor-Tir are essential for efficient *E. coli* O157:H7 colonization at the RAJ mucosa (Sheng et al., [@B64]). To test whether intimin or Tir had a role in internalization by the PBRE cells, we examined the ability of intimin or Tir deletion mutants of both 43894 and 43895 to enter the PBRE cells. Although internalization was slightly reduced for 43894Δ*eae*, a mutant in which intimin was deleted, it was not significantly different from the wild-type. However, the slight reduction in PBRE cell internalization of the 43894Δ*tir* mutants (log value 4.03 ± 0.11) compared to the wild-type (log value 4.73 ± 0.17) was significant (*P* \< 0.05; Figure [6](#F6){ref-type="fig"}), although not dramatic. Similar trends were observed in Tir and intimin mutants of 43895. Both 43895Δ*eae* and Δ*tir* showed reduced levels of internalization (log value 5.95 ± 0.25, 6.03 ± 0.21, respectively); however, these decreased levels were not significant compared to wild-type 43895 (log value 6.33 ± 0.19; *P* \> 0.05). Notably, the levels of 43895Δ*eae* and Δ*tir* internalization were significantly higher than the wild-type 43894, its corresponding mutants (43894Δ*eae* and 43894Δ*tir*; *P* \< 0.001; Figure [6](#F6){ref-type="fig"}). The data showed strain variation in that deletion of Tir did not affect the high internalization properties of 43895, but did reduce the lower internalization properties of strain 43894 in PBRE cells.

![**The effect of the deletion of intimin or Tir on PBRE cell internalization of *E. coli* O157:H7**. *E. coli* O157:H7 43894 or 43895 and the derivatives lacking intimin (Δ*eae*) or Tir (Δ*tir*) with the monolayer of the PBRE cells at 100 MOI. The number of bacteria recovered after gentamicin treatment indicated the number internalized by the epithelial cells. The experiment was repeated three times with three replicated wells. Bars represent means ± SE. Significant difference compared with wild-type *E. coli* O157:H7 is indicated by the asterisk (*P* \< 0.05).](fmicb-02-00032-g006){#F6}

43895 is most efficient in biofilm formation
--------------------------------------------

Because the pattern of adherence appear aggregative for 43895, the *E. coli* O157:H7 strains used in this study were assessed for biofilm formation in a standard microtiter plate crystal violet biofilm assay in which formation of bacterial matrices attached to the plastic wells were quantified. 43895 formed more biofilm (*P* \< 0.05), with mean optical densities of 0.55 ± 0.043, than 43894 (0.09 ± 0.02), Sakai (0.14 ± 0.05), or WSU180 (0.11 ± 0.03; Figure [7](#F7){ref-type="fig"}). The enhanced ability of 43895 biofilm formation correlated with its enhanced ability to adhere to and enter PBEC cells.

![***Escherichia coli* O157:H7 biofilm formation in crystal violet assays**. The *E. coli* O157:H7 strains indicated were incubated at 37°C in MSM containing 4% glucose for 24 h in 96-well microtiter plate under stationary condition. Biofilm formation was measured by the absorbance of solubilized dye in 95% ethanol at 595 nm. The assays were performed six times for each isolate. All values are means and SE. Significant difference is indicated by the asterisk (*P* \< 0.05).](fmicb-02-00032-g007){#F7}

Strain 43895 persists longer than 43894 in cattle
-------------------------------------------------

Retrospective analysis of previous studies in which cattle were challenged with a single rectal application of 10^7^ CFU of *E. coli* O157:H7 43895 or 43894 was done to compare durations of bacterial carriage. The proportion of animals that were culture positive for *E. coli* O157:H7 from each group on each sampling day was compared and shown in Figure [8](#F8){ref-type="fig"}. There was a difference (*P* \< 0.05) between 43895 challenged animals (*n* = 22) and 43894 challenged animals (*n* = 14) determined using the Log-rank (Mantel--Cox) test. The median duration of carriage with 43895 or 43894 was 34 and 25 days, respectively. The detection limit for *E. coli* O157:H7 carriage, as previously described for enrichment culture, was 10 CFU/swab (Kudva et al., [@B38]; Sheng et al., [@B64]). This result indicated that *E. coli* O157:H7 strain 43895 persisted in cattle longer than strain 43894 and correlated with its increased internalization by host cells.

![**Differential persistence of *E. coli* O157:H7 in cattle**. Cattle were challenged with 43895 (*n* = 22) or 43894 (*n* = 14) using a single rectal application of 10^7^ CFU of bacteria. Rectal swab samples from each animal was taken twice a week and cultured for *E. coli* O157:H7 until animals cleared the carriage of the bacteria. Percent survival indicated the percent of the cattle that were O157 culture positive. Survival time (duration of carriage) was defined as the number of days animals were cultured positive with *E. coli* O157:H7 and the *P* value was calculated by the Log-rank (Mantel--Cox) test.](fmicb-02-00032-g008){#F8}

Discussion
==========

The most important finding of this work was that a subpopulation of *E. coli* O157:H7 were internalized by epithelial cells at the bovine RAJ mucosa. This finding supports previous observations that not all *E. coli* O157:H7 are killed by phage lysis or by antimicrobials applied topically or fed. In addition, internalization of *E. coli* O157:H7 by cells at the RAJ mucosa may play a role in bacterial persistence in cattle. The conclusion that some bacteria are internalized and survive in bovine rectal epithelial cells was made both from tissue biopsies from culture positive cattle and from *in vitro* culture of bovine rectal epithelial cells. To accomplish the latter, primary cell culture techniques were adapted to culture epithelial cells from the RAJ mucosa of adult cattle.

The architecture of the bovine RAJ mucosa is comprised of epithelial cells lining crypts and the area is rich in lymphoid follicular tissue (Naylor et al., [@B51]). The intestinal epithelial cells at this site are rapidly dividing and originate from progenitor cells at the base of the crypt, migrate up and out of the crypt onto the luminal surface of the mucosa where they are shed (Magnuson et al., [@B42]). Estimates are that the epithelial cells lining the terminal rectum turnover every 4 days as older cells are sloughed and newly dividing cells emerge from the crypts (Falk et al., [@B20]; Sheng et al., [@B64]). Also, the average duration individual animals carry *E. coli* O157:H7 is 1 month (Besser et al., [@B3]). Cattle carrying *E. coli* O157:H7 are colonized at this tissue site and bacterial cells have been characterized in close association with the mucosa, attached to the surface of the host cells (Naylor et al., [@B51]). The parameters that trigger clearance or persistence in the carriage of *E. coli* O157:H7 are not fully understood but likely involve a dynamic between bacterial attachment to host cells, bacterial division, host cell division, and host cell turnover. *E. coli* O157:H7 internalization and survival in epithelial cells likely adds to this host:microbe interaction. In this study, the bacteria were present deep in the crypts and were able to survive gentamicin treatment of biopsied tissue that kills all extracellular bacteria. Also, *E. coli* O157:H7 attached to, were internalized by, and survived in cultured cells (PBRE) from this site.

Most pathogenic types of *E. coli* involved in gastrointestinal infections are able to invade cultured epithelial cells (Nataro and Kaper, [@B50]). Our findings showed that for *E. coli* O157:H7, the efficiency of internalization differed among the strains we tested. The uptake of ATCC 43895 by the PBRE cells was 19.38% of the original inoculum. This level is ∼100-fold higher than the other *E. coli* O157:H7 strains tested (Table [3](#T3){ref-type="table"}) and was at a level similar to previous studies done with a variety of cell lines (Matthews et al., [@B44]; Dibb-Fuller et al., [@B12]; Uhlich et al., [@B71], [@B70]; Abu-Ali et al., [@B1]). Also, ATCC 43895 was more proficient at forming biofilm compared to the other strains tested. These two phenotypes of enhanced host cell internalization and biofilm formation may be related and may contribute to the duration bacterial strains are carried by cattle. This idea is supported by the retrospective analysis of cattle challenged with a single rectal application of *E. coli* O157:H7 43895 or 43894 that showed strain 43895 persisted in cattle longer than strain 43894.

Bacterial internalization is associated with the rearrangement of the host cell cytoskeletal structure resulting in endocytosis of the pathogen (Goosney et al., [@B26]; Donnenberg, [@B14]). Most invasive enteric bacteria including *Salmonella*, *Shigella*, *Listeria*, and *Yersinia* spp. (Falkow et al., [@B21]; Finlay and Cossart, [@B22]; Mengaud et al., [@B47]) trigger largely microfilament-dependent entry pathways. Invasion of EPEC cells in tissue culture is inhibited by cytochalasin D, colchicines, and by broad specificity Rho GTPase inhibitors (Donnenberg et al., [@B15]; Ben-Ami et al., [@B2]). In contrast, *E. coli* O157:H7 internalization was inhibited by cytochalasin D (Figure [5](#F5){ref-type="fig"}) but not by other eukaryotic cell inhibitors. This suggests that *E. coli* O157:H7 uptake by the bovine epithelial cells was through a microfilament-dependent pathway. These data are in agreement with previous studies using immortal cell lines (Matthews et al., [@B44]) and indicate that EPEC and EHEC exploit distinct host cell processes to stimulate their uptake.

In addition to the actin-dependent host cell microfilament activity required for *E. coli* O157:H7 internalization by epithelial cells, bacterial factors play a role because strain differences in the rate of internalization were found. Tir was not required for efficient uptake of the more efficiently internalized ATCC 43895 strain, but its deletion affected the less efficiently internalized ATCC 43894, although this could be related to the differences in the number of internalized cells or a unique change in the association with the PBRE cells that affected the internalization rate. Close examination of the electron microscopy images of O157-infected PBRE cells showed the interaction between 43895 and PBRE cells was associated with microvilli-like extensions projecting from the host cell membranes and surrounding the bacteria (Figure [3](#F3){ref-type="fig"}B). In addition, Transmission electron microscopy of O157-infected PBRE cells showed bacteria enclosed by membrane-bound vacuoles. This suggests that the localized membrane elongations, which may be induced when the bacteria come into contact with the epithelial cell surface, play a role in the uptake by the PBRE cells. Also, EM images of cross sectioned cells showed \>10 intracellular 43895/epithelial cell. This number of intracellular bacteria is comparable with numbers previously reported for other enteric bacterial pathogens such as *Shigella flexneri* (Sansonetti et al., [@B61]) and *Salmonella typhimurium* (Leung and Finlay, [@B39]). Invasion of eukaryotic cells is known to be an important survival mechanism of these enteric pathogens (Finlay and Falkow, [@B23]). However, the internalization of O157 by RAJ epithelial cells is not associated with disease in cattle.

In conclusion, the internalization and survival of a subset of *E. coli* O157:H7 by epithelial cells at the bovine RAJ contributes to the host:microbe interaction. Further study will be required to determine the extent to which internalization contributes to persistence and/or the bovine immune response to this human pathogen and the mechanism of *E. coli* O157:H7 internalization by bovine epithelial cells.
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